Prescription Monitoring Program (PMP) Information
To manage the technical aspects of the program, the Board has partnered with Bamboo Health. They receive the transaction reports from all the dispensers, house the data on servers owned by the Board, and host the web portal for authorized direct access users. Bamboo Health has also authored technical assistance documents as provided below.
Annual Program Reports: 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010, 2009
Additional information about various aspects of the program is provided through the following links.
Information for Prescribers and Pharmacists
Registrants who wish to obtain access to the PMP must visit https://louisiana.pmpaware.net/login and select the Create an Account link to begin the process. During the registration process, the applicant will be required to provide specific information unique to them in addition to the Individual Access Code provided by the Board in order to gain immediate access.
Any registrant who has not received an Individual Access Code or is unable to complete the online registration process should contact the PMP office for assistance, at (225) 925-6496, selecting Option "4".
Once the PMP account has been established, the user will receive an approval email, along with an email verification request. These emails will come from no-reply@louisiana.PMPAWARE.net. Please adjust any email filters in place to recognize that address as a valid email address.
For detailed assistance, please refer to the User Registration Process Tutorial.
Suspected Fraudulent Activity - Prescribers
Authorized Clinicians - Therapeutic Marijuana Guidance
Statewide Integration of PMP into Electronic Health Record Systems
The Prescription Monitoring Program is implementing a statewide comprehensive platform for healthcare professionals to review patients' controlled substance prescription history more quickly and efficiently. The goal of the integration project is to minimize any workflow disruption by providing near-instant and seamless access to critical controlled substance prescription history information to both prescribers and pharmacists. This platform utilizes current PMP prescription data and transfers it into electronic health records (EHR) and pharmacy management systems. This statewide integration is a key component of Louisiana's ongoing efforts to address the opioid crisis. Accessing and viewing a patient's PMP report obtained through the integration platform complies with Louisiana's PMP Mandatory Use Law (R.S. 40:978). EHR and pharmacy management system representatives seeking connection to the integration platform should complete the Integration Request form which can be found in the Louisiana NarxCare EHR & Pharmacy Management System Integration Request page.
Information for Dispensers
Effective June 2, 2016 the reporting of eligible prescription transactions (Schedules II through V and drugs of concern) to the Louisiana PMP database must be submitted to the Bamboo Health Clearinghouse.
The Louisiana Prescription Monitoring Program (PMP) reporting requirements have transitioned from ASAP 4.2 format to ASAP 4.2B as of August 1, 2022. The Louisiana Data Submission Guide for Dispensers for both ASAP 4.2 and 4.2B are available below:
ASAP 4.2 |
ASAP 4.2B |
Please familiarize yourself with the reporting requirements and make sure your software vendor is aware of the changes. Any data not submitted in the appropriate format will generate errors.
The Louisiana Board of Pharmacy may issue an exemption from the Louisiana Prescription Monitoring Program (PMP) reporting requirement to a dispenser whose practice activities are inconsistent with the intent of the program. For those pharmacies seeking a waiver from the reporting requirements, please complete the PMP Exemption Request Form posted here and submit to the Board office by email or postal service.
Pharmacies reporting veterinary prescriptions to the PMP database should be aware of special procedures for certain data elements in such prescription transactions. The linked document provides detailed explanations.
Pharmacy Guidance: Reporting accurate prescriber information to the PMP.
User Support Resources
For more detailed assistance for the AWARxE program, please consult the AWARxE User Support Manual [v3.1 - November 2022] or Bamboo Health PMP AWARxE Support Center
For your convenience, we have constructed a Quick Reference Guide for Patient Data Search.